Kozak & Associates’s Templeton Emerging Markets Fund EMF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.97K Buy
131
+2
+2% +$43 ﹤0.01% 343
2026
Q1
$2.48K Sell
129
-17
-12% -$324 ﹤0.01% 358
2025
Q4
$2.67K Buy
146
+6
+4% +$102 ﹤0.01% 357
2025
Q3
$2.37K Buy
140
+2
+1% +$31 ﹤0.01% 373
2025
Q2
$2.06K Buy
138
+2
+1% +$26 ﹤0.01% 352
2025
Q1
$1.67K Buy
136
+2
+1% +$25 ﹤0.01% 372
2024
Q4
$1.62K Buy
134
+6
+5% +$77 ﹤0.01% 371
2024
Q3
$1.74K Hold
128
﹤0.01% 338
2024
Q2
$1.62K Hold
128
﹤0.01% 331
2024
Q1
$1.62K Hold
128
﹤0.01% 340
2023
Q4
$1.43K Buy
128
+7
+6% +$80 ﹤0.01% 330
2023
Q3
$1.35K Hold
121
﹤0.01% 350
2023
Q2
$1.45K Hold
121
﹤0.01% 320
2023
Q1
$1.42K Buy
121
+11
+10% +$131 ﹤0.01% 315
2022
Q4
$1K Hold
110
﹤0.01% 321
2022
Q3
$1K Hold
110
﹤0.01% 314
2022
Q2
$1K Hold
110
﹤0.01% 355
2022
Q1
$1K Hold
110
﹤0.01% 364
2021
Q4
$1K Buy
110
+7
+7% +$119 ﹤0.01% 364
2021
Q3
$2K Buy
+103
New +$1.86K ﹤0.01% 303

Other funds holding EMF

Kozak & Associates's EMF Position: Q2 2026 in Review

Kozak & Associates increased its Templeton Emerging Markets Fund (EMF) stake by 1.6% in Q2 2026, buying an estimated $43 and bringing the position to 131 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #343.

Kozak & Associates first reported a position in EMF in Q3 2021 and has held it in 20 quarters since. 4 funds tracked by Wall St. Rank hold EMF as of Q2 2026.

  • Kozak & Associates held 131 shares of Templeton Emerging Markets Fund worth $2.97K as of Q2 2026.
  • Kozak & Associates bought 2 Templeton Emerging Markets Fund shares in Q2 2026, an estimated $43.
  • Templeton Emerging Markets Fund made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #343 holding.
  • Kozak & Associates first reported a position in Templeton Emerging Markets Fund in Q3 2021 and has held it in 20 quarters since.
  • 4 funds tracked by Wall St. Rank held Templeton Emerging Markets Fund as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.